Paper20439609
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
Lanier ER and 9 others. Antimicrob Agents Chemother, 2010. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. Papers, record 20439609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20439609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenine | Major topic |
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Nucleosides | Major topic |
| Nucleotides | Major topic |
| Organophosphonates | Major topic |
| Cell Survival | |
| Cells, Cultured | |
| Drug Resistance, Viral | |
| HIV-1 | |
| Humans | |
| Macrophages | |
| Tenofovir |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17646420 | Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17646420 | PubMed |
| 2 | 18398970 | Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients. | J Acquir Immune Defic Syndr | 2008 | https://conductscience.org/library/papers/18398970 | PubMed |
| 3 | 10479128 | Viral and immunologic examination of human immunodeficiency virus type 1-infected, persistently seronegative persons. | J Infect Dis | 1999 | https://conductscience.org/library/papers/10479128 | PubMed |
| 4 | 17106280 | Predictors of antiretroviral treatment failure in an urban HIV clinic. | J Acquir Immune Defic Syndr | 2007 | https://conductscience.org/library/papers/17106280 | PubMed |
| 5 | 9620997 | Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. | J Virol | 1998 | https://conductscience.org/library/papers/9620997 | PubMed |
| 6 | 10207549 | Persistently negative HIV-1 antibody enzyme immunoassay screening results for patients with HIV-1 infection and AIDS: serologic, clinical, and virologic results. Seronegative AIDS Clinical Study Group. | AIDS | 1999 | https://conductscience.org/library/papers/10207549 | PubMed |
| 7 | 9094670 | Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. | J Virol | 1997 | https://conductscience.org/library/papers/9094670 | PubMed |
| 8 | 14976601 | Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients. | J Infect Dis | 2004 | https://conductscience.org/library/papers/14976601 | PubMed |
| 9 | 15633092 | Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15633092 | PubMed |
| 10 | 3258626 | Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. | J Exp Med | 1988 | https://conductscience.org/library/papers/3258626 | PubMed |
| 11 | 6200935 | Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. | Science | 1984 | https://conductscience.org/library/papers/6200935 | PubMed |
| 12 | 3481271 | Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. | AIDS Res Hum Retroviruses | 1987 | https://conductscience.org/library/papers/3481271 | PubMed |
| 13 | 20068260 | Update of the drug resistance mutations in HIV-1: December 2009. | Top HIV Med | 2009 | https://conductscience.org/library/papers/20068260 | PubMed |
| 14 | 9243042 | Absence of detectable antibody in a patient infected with human immunodeficiency virus. | Clin Infect Dis | 1997 | https://conductscience.org/library/papers/9243042 | PubMed |
| 15 | 19289522 | Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19289522 | PubMed |
| 16 | 17005808 | Mechanism of active renal tubular efflux of tenofovir. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/17005808 | PubMed |
| 17 | 14742192 | Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14742192 | PubMed |
| 18 | 15283988 | Design and development of oral drugs for the prophylaxis and treatment of smallpox infection. | Trends Biotechnol | 2004 | https://conductscience.org/library/papers/15283988 | PubMed |
| 19 | 1729362 | Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN. | J Immunol | 1992 | https://conductscience.org/library/papers/1729362 | PubMed |
| 20 | 9256156 | Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. | Biochem Pharmacol | 1997 | https://conductscience.org/library/papers/9256156 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40969871 | Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron Incorporation. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40969871 | PubMed |
| 38005911 | The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors. | Viruses | 2023 | https://conductscience.org/library/papers/38005911 | PubMed |
| 36477356 | Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques. | JCI Insight | 2022 | https://conductscience.org/library/papers/36477356 | PubMed |
| 35891417 | HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala (Thymelaeaceae). | Viruses | 2022 | https://conductscience.org/library/papers/35891417 | PubMed |
| 34985256 | Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation. | ACS Infect Dis | 2022 | https://conductscience.org/library/papers/34985256 | PubMed |
| 33490040 | Overview of Biologically Active Nucleoside Phosphonates. | Front Chem | 2020 | https://conductscience.org/library/papers/33490040 | PubMed |
| 33262821 | Investigational drugs with dual activity against HBV and HIV (Review). | Exp Ther Med | 2021 | https://conductscience.org/library/papers/33262821 | PubMed |
| 32389360 | Hepatitis B: Current Status of Therapy and Future Therapies. | Gastroenterol Clin North Am | 2020 | https://conductscience.org/library/papers/32389360 | PubMed |
| 31469328 | Phosphonate prodrugs: an overview and recent advances. | Future Med Chem | 2019 | https://conductscience.org/library/papers/31469328 | PubMed |
| 29802984 | Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema. | Eur J Pharm Biopharm | 2019 | https://conductscience.org/library/papers/29802984 | PubMed |
| 29433097 | Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs. | J Pharm Biomed Anal | 2018 | https://conductscience.org/library/papers/29433097 | PubMed |
| 26088266 | Investigational reverse transcriptase inhibitors for the treatment of HIV. | Expert Opin Investig Drugs | 2015 | https://conductscience.org/library/papers/26088266 | PubMed |
| 25849312 | β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms. | J Med Chem | 2015 | https://conductscience.org/library/papers/25849312 | PubMed |
| 25302989 | Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication. | J Chem Inf Model | 2014 | https://conductscience.org/library/papers/25302989 | PubMed |
| 24278679 | The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance. | Scientifica (Cairo) | 2012 | https://conductscience.org/library/papers/24278679 | PubMed |
| 24217696 | Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24217696 | PubMed |
| 23722347 | Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/23722347 | PubMed |
| 23554824 | Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors. | Drug Discov Today Technol | 2012 | https://conductscience.org/library/papers/23554824 | PubMed |
| 22912836 | Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens. | PLoS One | 2012 | https://conductscience.org/library/papers/22912836 | PubMed |
| 22878694 | Update on tenofovir toxicity in the kidney. | Pediatr Nephrol | 2013 | https://conductscience.org/library/papers/22878694 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20439609
GET https://conductscience.org/api/papers/v1/20439609/references?page=2